Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Musashi Seimitsu Industry is a global Tier 1 automotive parts manufacturer that has strategically diversified into the life sciences and well-being sectors. Through its "Well-being" business segment and the "M Lab" research initiative, the company focuses on the development of functional plant-based ingredients and phytochemical therapies. Musashi collaborates with academic institutions like Toyohashi University of Technology to research botanical extracts from the East Mikawa region, which are commercialized through its investment in the wellness brand Waphyto. The company leverages its advanced manufacturing and AI capabilities to innovate in sustainable health, agriculture, and regenerative medicine support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Musashi Seimitsu.